[PDF][PDF] Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study

MZ Hao, HL Lin, Q Chen, YB Ye, QZ Chen… - Chin J Cancer, 2010 - academia.edu
… recent 6 months, chronic heart failure or unstable coronary artery diseaseanalysis
demonstrated that ECOG performance status, CIK cell therapy, and times of TACE before disease

[PDF][PDF] Research Progress of Exosomes in Cardiovascular Diseases

H Cheng, C Luo, J Ma - Adv Clin Med, 2019 - pdf.hanspub.org
diseases and play an important role in diagnosis and treatment of cardiovascular diseases.
… and development of cardiovascular diseases by affecting cell proliferation, apoptosis and …

[PDF][PDF] Mineralocorticoid receptor gene-2G/C polymorphism in central serous chorioretinopathy and relation of polymorphism with plasma cortisol levels

A Yazici, ES Sari, B Eser, G Sahin… - International Eye …, 2016 - researchgate.net
… Student蒺s t-test for parametric analysis and Mann - Whitney U test for nonparametric
analysis was used for searching intergroup difference. One -way ANOVA test was used for …

Guanxin II (冠心II 号) for the management of coronary heart disease

F Qin, X Huang - Chinese journal of integrative medicine, 2009 - Springer
assessment. It has been demonstrated that Guanxin Ⅱ has beneficial effects on coronary
heart disease (CHD). The underlying mechanism was proved to be its anti-ischemic, anti-…

[HTML][HTML] … of Lingbao Huxin Dan (灵宝护心丹) in the treatment of bradyarrhythmia complicated with coronary heart disease: a network pharmacology analysis

HAN Huagang, LI Ziqiang, J OUYANG… - Journal of Traditional …, 2023 - ncbi.nlm.nih.gov
… In the present study PPI network analysis identified 11 potential therapeutic targets, among
which were 9 key targets, including ADRB1, ADRA1A, CACNA1C, ADRA1B, NOS2, ADRB2, …

Network pharmacology-based exploration of synergistic mechanism of guanxin II formula (冠心II 号方) for coronary heart disease

S Sheng, Z Yang, F Xu, Y Huang - Chinese journal of integrative medicine, 2021 - Springer
Coronary heart disease (CHD) is the leading serious health … plaques which obstruct coronary
arteries that supply and nourish … in coronary heart disease: a collaborative meta-analysis of …

Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus

Y Zhang, B Lu, M Zhao, Y Rong, R Chen - Chinese journal of integrative …, 2008 - Springer
… in the pathogenesis of coronary heart disease (CHD), and is a crucial cause for its aggravation(…
when treating ischemic heart diseases, the use of conventional treatment complemented …

Shenfu Injection (参附注射液) suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure

S Zheng, H Wu, S Yu, J Ren, W Duo, Z Ma… - Chinese journal of …, 2015 - Springer
… from any structural or functional cardiac disorder that impairs the … of several disease states
such as coronary artery disease, … and in the evaluation of new therapies for heart failure. …

Cardioprotective effects of Qishen Granule (芪参颗粒) on sarcoplasmic reticulum Ca2+ handling in heart failure rats

L Lu, C Li, Q Wang, Q Zhang, Y Zhang, H Meng… - Chinese journal of …, 2017 - Springer
cardiac cycles were picked for measurement in each rat and the mean values of the above
indicators were recorded for following statistical analysis… concomitant ischemic heart disease

Efficacy and Safety Evaluation of Taohong Siwu Decoction (桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials

T Tao, H Mao, L Xia, X Liu - Chinese journal of integrative medicine, 2021 - Springer
… (20,21) or 2013 ESC guidelines on the management of stable coronary artery disease.(3)
(3) Types of interventions: Trials including intervention and comparison of any of the followings …